Recent studies have suggested that CCR6 polymorphisms are associated with an increased risk for a variety of autoimmune- or immune-mediated diseases, such as rheumatoid arthritis (RA) [19,20], Crohn’s disease [21], systemic sclerosis (SSc) [22] and vitiligo [23]. The gene discussed is CCR6; the disease is systemic sclerosis.